Immunoregulation of Autoimmune Diseases

Human Immunology

Volumn 67, Issue 6, 2006, Pages 446-453

  van Eden, Willem ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HEAT SHOCK PROTEIN 60; HEAT SHOCK PROTEIN 70; MAJOR HISTOCOMPATIBILITY ANTIGEN; T LYMPHOCYTE RECEPTOR;

ALLERGIC DISEASE; ANTIGEN PRESENTING CELL; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BACTERIAL INFECTION; CELLULAR IMMUNITY; CHRONIC INFLAMMATION; CLINICAL TRIAL; HUMAN; IMMUNE RESPONSE GENE; IMMUNE SYSTEM; IMMUNITY; IMMUNOREGULATION; INSULIN DEPENDENT DIABETES MELLITUS; LIFESTYLE; MAJOR HISTOCOMPATIBILITY COMPLEX; MORBIDITY; MULTIPLE SCLEROSIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; RHEUMATOID ARTHRITIS; SUPPRESSOR CELL; T LYMPHOCYTE;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, BACTERIAL; AUTOANTIBODIES; AUTOIMMUNE DISEASES; BACTERIAL INFECTIONS; BACTERIAL PROTEINS; CHAPERONIN 60; HLA ANTIGENS; HSP70 HEAT-SHOCK PROTEINS; HUMANS; IMMUNE TOLERANCE; INFLAMMATION; MAJOR HISTOCOMPATIBILITY COMPLEX; PEPTIDE FRAGMENTS; POLYMORPHISM, GENETIC; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY;

EID: 33646799481     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2006.03.010     Document Type: Review

References (40)

1. van Eden W., and van Rood J.J. Genetic regulation of immune responsiveness in man. In: Hunter D.P. (Ed). Immunological Aspects of Leprosy, Tuberculosis and Leishmaniasis (1981), Excerpta Medica, Amsterdam, Oxford, Princeton 201
2. Babbitt B.P., Allen P.M., Matsueda G., Haber E., and Unanue E.R. Binding of immunogenic peptides to la histocompatibility molecules. Nature 317 6035 (1985) 359
3. Holoshitz J., Naparstek Y., Ben-Nun A., and Cohen I.R. Lines of T lymphocytes induce or vaccinate against autoimmune arthritis. Science 219 4580 (1983) 56
4. Sakaguchi S. Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 22 (2004) 531
5. Knoechel B., Lohr J., Kahn E., Bluestone J.A., and Abbas A.K. Sequential development of interleukin 2-dependent effector and regulatory T cells in response to endogenous systemic antigen. J Exp Med 202 10 (2005) 1375
6. Gale E.A. The rise of childhood type 1 diabetes in the 20th century. Diabetes 51 12 (2002) 3353
7. Poser S., Stickel B., Krtsch U., Burckhardt D., and Nordman B. Increasing incidence of multiple sclerosis in South Lower Saxony, Germany. Neuroepidemiology 8 4 (1989) 207
8. Loftus Jr. E.V. Clinical epidemiology of inflammatory bowel disease. Incidence, prevalence, and environmental influences. Gastroenterology 126 6 (2004) 1504
9. Sawczenko A., Sandhu B.K., Logan R.F., Jenkins H., Taylor C.J., Mian S., and Lynn R. Prospective survey of childhood inflammatory bowel disease in the British Isles. Lancet 357 9262 (2001) 1093
10. Bach J.F. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 347 12 (2002) 911
11. Uhlig T., and Kvien T.K. Is rheumatoid arthritis disappearing?. Ann Rheum Dis 64 1 (2005) 7
12. Anderson M.S., Venanzi E.S., Klein L., Chen Z., Berzins S.P., Turley S.J., von Boehmer H., Bronson R., Dierich A., Benoist C., and Mathis D. Projection of an immunological self shadow within the thymus by the aire protein. Science 298 5597 (2002) 1395
13. Criswell L.A., Pfeiffer K.A., Lurn R.F., Gonzales B., Novitzke J., Kern M., Moser K.L., Begovich A.B., Carlton V.E., Li W., Lee A.T., Ortmann W., Behrens T.W., and Gregersen P.K. Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection. the PTPN22 620W allele associates with multiple autoimmune phenotypes. Am J Hum Genet 76 4 (2005) 561
14. Viglietta V., Baecher-Allan C., Weiner H.L., and Hafler D.A. Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med 199 7 (2004) 971
15. Arif S., Tree T.I., Astill T.P., Tremble J.M., Bishop A.J., Dayan C.M., Roep B.O., and Peakman M. Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health. J Clin Invest 113 3 (2004) 451
16. Cao D., Malmstrom V., Baecher-Allan C., Hafler D., Klareskog L., and Trollmo C. Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis. Eur J Immunol 33 1 (2003) 215
17. van Amelsfort J.M., Jacobs K.M., Bijlsma J.W., Lafeber F.P., and Taams L.S. CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis. differences in the presence, phenotype, and function between peripheral blood and synovial fluid. Arthritis Rheum 50 9 (2004) 2775
18. King C., Ilic A., Koelsch K., and Sarvetrick N. Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell 117 2 (2004) 265
19. Rook G.A., and Stanford J.L. Give us this day our daily germs. Immunol Today 19 3 (1998) 113
20. Weinstock J.V., Summers R.W., and Elliott D.E. Role of helminths in regulating mucosal inflammation. Springer Semin Immunopathol 27 2 (2005) 249
21. Rook G.A., Adams V., Hunt J., Palmer R., Martinelli R., and Brunet L.R. Mycobacteria and other environmental organisms as immunomodulators for immunoregulatory disorders. Springer Semin Immunopathol 25 3-4 (2004) 237
22. Ochsenkuhn T., Weber M.M., and Caselmann W.H. Arthritis after Mycobacterium bovis immunotherapy for bladder cancer. [letter, comment]. Ann Intern Med 112 11 (1990) 882
23. van Eden W., Thole J.E., van der Zee R., Noordzij A., van Embden J.D., Hensen E.J., and Cohen I.R. Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis. Nature 331 6152 (1988) 171
24. Kingston A.E., Hicks C.A., Colston M.J., and Billingham M.E. A 71-kD heat shock protein (HSP) from Mycobacterium tuberculosis has modulatory effects on experimental rat arthritis. Clin Exp Immunol 103 1 (1996) 77
25. van Eden W., Hogervorst E.J., Wauben M.H., van der Zee R., and Boog C.J. Heat-shock proteins as antigens in autoimmunity. Biochem Soc Trans 19 1 (1991) 171
26. van den Broek M.F., Hogervorst E.J., Van Bruggen M.C., Van Eden W., van der Zee R., and van den Berg W.B. Protection against streptococcal cell wall-induced arthritis by pretreatment with the 65-kD mycobacterial heat shock protein. J Exp Med 170 2 (1989) 449
27. Thompson S.J., Francis J.N., Siew L.K., Webb G.R., Jenner P.J., Colston M.J., and Elson C.J. An immunodominant epitope from mycobacterial 65-kDa heat shock protein protects against pristane-induced arthritis. J Immunol 160 9 (1998) 4628
28. Anderton S.M., van der Zee R., Prakken B., Noordzij A., and van Eden W. Activation of T cells recognizing self 60-kD heat shock protein can protect against experimental arthritis. J Exp Med 181 3 (1995) 943
29. Wendling U., Paul L., van Der Zee R., Prakken B., Singh M., and van Eden W. A conserved mycobacterial heat shock protein (HSP) 70 sequence prevents adjuvant arthritis upon nasal administration and induces IL-10-producing T cells that cross-react with the mammalian self-HSP70 homologue. [In Process Citation]. J Immunol 164 5 (2000) p2711
30. Tanaka S. Activation of T Cells Recognizing an Epitope of Heat-Shock Protein 70 Can Protect Against Rat Adjuvant Arthritis. [Record Supplied By Publisher]. J Immunol 163 10 (1999) p5560
31. van Eden W., Hauet-Broere F., Berlo S., Paul L., van der Zee R., de Kleer I., Prakken B., and Taams L. Stress proteins as inducers and targets of regulatory T cells in arthritis. Int Rev Immunol 24 3-4 (2005) 181
32. Paul A.G., van Der Zee R., Taams L.S., and van Eden W. A self-HSP60 peptide acts as a partial agonist inducing expression of B7-2 on mycobacterial HSP60-specific T cells. a possible mechanism for inhibitory T cell regulation of adjuvant arthritis?. Int Immunol 12 7 (2000) 1041
33. van Eden W., Wendling U., Paul L., Prakken B., van Kooten P., and van der Zee R. Arthritis protective regulatory potential of self-heat shock protein cross-reactive T cells. Cell Stress Chaperones 5 5 (2000) 452
34. Wauben M.H., Boog C.J., van der Zee R., Joosten I., Schlief A., and van Eden W. Disease inhibition by major histocompatibility complex binding peptide analogues of disease-associated epitopes. more than blocking alone. J Exp Med 176 3 (1992) 667
35. Steinman L., Utz P.J., and Robinson W.H. Suppression of autoimmunity via microbial mimics of altered peptide ligands. Curr Top Microbiol Immunol 296 (2005) 55
36. Zhang J.W. T cell vaccination as an immunotherapy for autoimmune diseases. Cell Mol Immunol 1 5 (2004) 321
37. Broeren C.P., Lucassen M.A., van Stipdonk M.J., van der Zee R., Boog C.J., Kusters J.G., and van Eden W. CDR1 T-cell receptor beta-chain peptide induces major histocompatibility complex class II-restricted T-T cell interactions. Proc Natl Acad Sci USA 91 13 (1994) 5997
38. Raz I., Elias D., Avron A., Tamir M., Metzger M., and Cohen I.R. Beta-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277). a randomised, double-blind, phase II trial. Lancet 358 9295 (2001) 1749
39. Prakken B.J., Samodal R., Le T.D., Giannoni F., Yung G.P., Scavulli J., Amox D., Roord S., de Kleer I., Bonnin D., Lanza P., Berry C., Massa M., Billetta R., and Albani S. Epitope-specific immunotherapy induces immune deviation of proinflammatory T cells in rheumatoid arthritis. Proc Natl Acad Sci USA 101 12 (2004) 4228
40. Kamphuis S., Kuis W., de Jager W., Teklenburg G., Massa M., Gordon G., Boerhof M., Rijkers G.T., Uiterwaal C.S., Otten H.G., Sette A., Albani S., and Prakken B.J. Tolerogenic immune responses to novel T-cell epitopes from heat-shock protein 60 in juvenile idiopathic arthritis. Lancet 366 9479 (2005) 50